Drug Maker Actelion

CA 2018 Independent Pharmacies

DOJ False Claims Act Anti Kickback

Penalty

$360 million

Outcome

Drug Maker Actelion Agrees to Pay $360 Million to Resolve False Claims Act Liability for Paying Kickbacks

Details

Drug Maker Actelion — DOJ Enforcement (2018)

DOJ took enforcement action against Drug Maker Actelion in CA in 2018 involving false claims act, anti kickback violations in the Independent Pharmacies sector.

Penalty: $360 million

Violation types: False Claims Act, Anti Kickback
Entity type: Pharmacy
Penalty type: Settlement
Location: CA

Source: DOJ Press Release — Drug Maker Actelion Agrees to Pay $360 Million to Resolve False Claims Act Liability for Paying Kickbacks

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted. Crucible monitors referral patterns and financial arrangements to flag potential anti-kickback violations.

Source: DOJ Press Release — Drug Maker Actelion Agrees to Pay $360 Million to Resolve False Claims Act Liability for Paying Kickbacks

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works